Modulation of Semaphorin 3C & 4D Expression in Cancerous Tissues from Individuals with Laryngeal Squamous Cell Carcinoma

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2023 Nov 25

PMID 38006346

Authors

Marzieh Sajadian

Bijan Khademi

Leila Moinzadeh

Abbas Ghaderi

Abdollah Jafarzadeh

Mahboobeh Razmkhah

Affiliations

Soon will be listed here.

Abstract

Background Objectives: Semaphorins were initially characterized as axon guidance factors but were subsequently implicated in the regulation of immune responses, angiogenesis, organ formation and a variety of other physiological and developmental functions. Various semaphorins enhance or inhibit tumour progression through different mechanisms. The objective of this study was to assess the expression of various semaphorins and vascular endothelial growth factor (VEGF) gene transcripts as well as the serum level of Sema3A in individuals with laryngeal squamous cell carcinoma (LSCC).

Methods: Tissue expression of Sema3A, Sema3C, Sema4D, Sema6D and VEGF was determined in both tumour tissues and tissues around the tumour from 30 individuals with pathologically confirmed LSCC using quantitative real-time PCR. Furthermore, the serum level of Sema3A in these individuals was assessed using enzyme-linked immunosorbent assay.

Results: Sema3C gene transcript showed a significant increase (P=0.001), while Sema4D was observed with a significant decrease in tumour samples compared to non-tumoural tissues (P≤0.01). The expression of the Sema3C gene was found to be associated with the stage of LSCC tumour as it was statistically significant for tumours with stage IV (P<0.01). The serum level of Sema3A was not found to be significant between cases and controls.

Interpretation Conclusions: Increased expression of Sema3C but decreased expression of Sema4D in tumour tissue of LSCC may introduce these two growth factors as crucial mediators orchestrating tumour growth in individuals with LSCC. This result could open a new vision for the treatment of this malignancy.

References

Zhang D, Lindstrom A, Kim E, Hwang C, Hall M, Lin T . SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment. Front Oncol. 2022; 12:890154. PMC: 9243227. DOI: 10.3389/fonc.2022.890154. View

Mansourabadi Z, Razmkhah M, Mohtasebi M, Talei A, Ghaderi A . Expression of major histocompatibility complex class I polypeptide-related sequence B in adipose-derived stem cells from breast cancer patients and normal individuals. J Cancer Res Ther. 2019; 15(5):1067-1072. DOI: 10.4103/jcrt.JCRT_866_16. View

Rajabi M, Mousa S . The Role of Angiogenesis in Cancer Treatment. Biomedicines. 2017; 5(2). PMC: 5489820. DOI: 10.3390/biomedicines5020034. View

Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K . The semaphorins and their receptors as modulators of tumor progression. Drug Resist Updat. 2016; 29:1-12. DOI: 10.1016/j.drup.2016.08.001. View

Granziero L, Circosta P, Scielzo C, Frisaldi E, Stella S, Geuna M . CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood. 2002; 101(5):1962-9. DOI: 10.1182/blood-2002-05-1339. View

Xu X, Zhao Z, Guo S, Li J, Liu S, You Y . Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. Cancer Lett. 2017; 397:12-22. DOI: 10.1016/j.canlet.2017.03.014. View

He Y, Cheng Y, Huang Z, Xu W, Hu R, Cheng L . A deep convolutional neural network-based method for laryngeal squamous cell carcinoma diagnosis. Ann Transl Med. 2022; 9(24):1797. PMC: 8756237. DOI: 10.21037/atm-21-6458. View

Ferreira G, Capp E, Jauckus J, Strowitzki T, Germeyer A . Expression of semaphorin class 3 is higher in the proliferative phase on the human endometrium. Arch Gynecol Obstet. 2018; 297(5):1175-1179. DOI: 10.1007/s00404-018-4719-3. View

Iragavarapu-Charyulu V, Wojcikiewicz E, Urdaneta A . Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?. Front Immunol. 2020; 11:346. PMC: 7066498. DOI: 10.3389/fimmu.2020.00346. View

10.

Sitohy B, Nagy J, Dvorak H . Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res. 2012; 72(8):1909-14. PMC: 3335750. DOI: 10.1158/0008-5472.CAN-11-3406. View

11.

Mishra R, Thorat D, Soundararajan G, Pradhan S, Chakraborty G, Lohite K . Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. Oncogene. 2014; 34(12):1584-95. DOI: 10.1038/onc.2014.79. View

12.

Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K . The role of the semaphorins in cancer. Cell Adh Migr. 2016; 10(6):652-674. PMC: 5160032. DOI: 10.1080/19336918.2016.1197478. View

13.

Peacock J, Takeuchi A, Hayashi N, Liu L, Tam K, Al Nakouzi N . SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1. EMBO Mol Med. 2018; 10(2):219-238. PMC: 5801490. DOI: 10.15252/emmm.201707689. View

14.

Muller M, Giese N, Swiercz J, Ceyhan G, Esposito I, Hinz U . Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer. 2007; 121(11):2421-33. DOI: 10.1002/ijc.22949. View

15.

Zhao X, Chen L, Xu Q, Li Y . Expression of semaphorin 6D in gastric carcinoma and its significance. World J Gastroenterol. 2006; 12(45):7388-90. PMC: 4087504. DOI: 10.3748/wjg.v12.i45.7388. View

16.

Neufeld G, Sabag A, Rabinovicz N, Kessler O . Semaphorins in angiogenesis and tumor progression. Cold Spring Harb Perspect Med. 2012; 2(1):a006718. PMC: 3253028. DOI: 10.1101/cshperspect.a006718. View

17.

Bagci T, Wu J, Pfannl R, Ilag L, Jay D . Autocrine semaphorin 3A signaling promotes glioblastoma dispersal. Oncogene. 2009; 28(40):3537-50. DOI: 10.1038/onc.2009.204. View

18.

Rajabinejad M, Asadi G, Ranjbar S, Afshar Hezarkhani L, Salari F, Gorgin Karaji A . Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer. Gene. 2020; 746:144637. DOI: 10.1016/j.gene.2020.144637. View

19.

Rao X, Huang X, Zhou Z, Lin X . An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2015; 3(3):71-85. PMC: 4280562. View

20.

Toledano S, Nir-Zvi I, Engelman R, Kessler O, Neufeld G . Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression. Int J Mol Sci. 2019; 20(3). PMC: 6387194. DOI: 10.3390/ijms20030556. View